Article Versions Notes

Knittelfelder O, Delago D, Jakse G, Lukasiak K, Thurner E-M, Thurnher D, Pichler M, Renner W, Stranzl-Lawatsch H, Langsenlehner T. The Pre-Treatment C-Reactive Protein Represents a Prognostic Factor in Patients with Oral and Oropharyngeal Cancer Treated with Radiotherapy. Cancers. 2020; 12(3):626. https://doi.org/10.3390/cancers12030626

Knittelfelder, Olivia, Daniela Delago, Gabriele Jakse, Katarzyna Lukasiak, Eva-Maria Thurner, Dietmar Thurnher, Martin Pichler, Wilfried Renner, Heidi Stranzl-Lawatsch, and Tanja Langsenlehner. 2020. "The Pre-Treatment C-Reactive Protein Represents a Prognostic Factor in Patients with Oral and Oropharyngeal Cancer Treated with Radiotherapy" Cancers 12, no. 3: 626. https://doi.org/10.3390/cancers12030626

Knittelfelder, O., Delago, D., Jakse, G., Lukasiak, K., Thurner, E.-M., Thurnher, D., Pichler, M., Renner, W., Stranzl-Lawatsch, H., & Langsenlehner, T. (2020). The Pre-Treatment C-Reactive Protein Represents a Prognostic Factor in Patients with Oral and Oropharyngeal Cancer Treated with Radiotherapy. Cancers, 12(3), 626. https://doi.org/10.3390/cancers12030626